Advantages of using denosumab for osteoporosis
Today the arsenal of general practitioner includes a sufficient number of effective drugs for osteoporosis therapy. According to recent recommendations of Russian Association on Osteoporosis, apart from nitrogen-containing bisphosphonates and strontium ranelate, denosumab is also considered a first...
| Published in: | Медицинский совет |
|---|---|
| Main Authors: | , |
| Format: | Article |
| Language: | Russian |
| Published: |
Remedium Group LLC
2013-12-01
|
| Subjects: | |
| Online Access: | https://www.med-sovet.pro/jour/article/view/893 |
| _version_ | 1850129423102115840 |
|---|---|
| author | O. B. Ershova A. V. Nazarova |
| author_facet | O. B. Ershova A. V. Nazarova |
| author_sort | O. B. Ershova |
| collection | DOAJ |
| container_title | Медицинский совет |
| description | Today the arsenal of general practitioner includes a sufficient number of effective drugs for osteoporosis therapy. According to recent recommendations of Russian Association on Osteoporosis, apart from nitrogen-containing bisphosphonates and strontium ranelate, denosumab is also considered a first choice drug for the treatment of osteoporosis. Its clinical efficiency in reducing the risk of (extra)vertebral fractures is proved by long-term multicentre trials. |
| format | Article |
| id | doaj-art-a15ffbca11294a57b592ce7dcdcd1668 |
| institution | Directory of Open Access Journals |
| issn | 2079-701X 2658-5790 |
| language | Russian |
| publishDate | 2013-12-01 |
| publisher | Remedium Group LLC |
| record_format | Article |
| spelling | doaj-art-a15ffbca11294a57b592ce7dcdcd16682025-08-19T23:53:15ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902013-12-0102-2727710.21518/2079-701X-2013-2-2-72-77893Advantages of using denosumab for osteoporosisO. B. Ershova0A. V. Nazarova1Clinical Hospital of Emergency Care named after N.V.Solovyov, Yaroslavl regionClinical Hospital of Emergency Care named after N.V.Solovyov, Yaroslavl regionToday the arsenal of general practitioner includes a sufficient number of effective drugs for osteoporosis therapy. According to recent recommendations of Russian Association on Osteoporosis, apart from nitrogen-containing bisphosphonates and strontium ranelate, denosumab is also considered a first choice drug for the treatment of osteoporosis. Its clinical efficiency in reducing the risk of (extra)vertebral fractures is proved by long-term multicentre trials.https://www.med-sovet.pro/jour/article/view/893остеопорозбисфосфонатыхроническая почечная недостаточностьosteoporosisbisphosphonateschronic renal failure |
| spellingShingle | O. B. Ershova A. V. Nazarova Advantages of using denosumab for osteoporosis остеопороз бисфосфонаты хроническая почечная недостаточность osteoporosis bisphosphonates chronic renal failure |
| title | Advantages of using denosumab for osteoporosis |
| title_full | Advantages of using denosumab for osteoporosis |
| title_fullStr | Advantages of using denosumab for osteoporosis |
| title_full_unstemmed | Advantages of using denosumab for osteoporosis |
| title_short | Advantages of using denosumab for osteoporosis |
| title_sort | advantages of using denosumab for osteoporosis |
| topic | остеопороз бисфосфонаты хроническая почечная недостаточность osteoporosis bisphosphonates chronic renal failure |
| url | https://www.med-sovet.pro/jour/article/view/893 |
| work_keys_str_mv | AT obershova advantagesofusingdenosumabforosteoporosis AT avnazarova advantagesofusingdenosumabforosteoporosis |